Europlasma S.A.

ENXTPA:ALEUP Stock Report

Market Cap: €7.5k

Europlasma Past Earnings Performance

Past criteria checks 0/6

Europlasma's earnings have been declining at an average annual rate of -30.7%, while the Commercial Services industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 46.1% per year.

Key information

-30.67%

Earnings growth rate

81.66%

EPS growth rate

Commercial Services Industry Growth11.81%
Revenue growth rate46.10%
Return on equityn/a
Net Margin-50.54%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

Analysis Article Aug 08

Take Care Before Jumping Onto Europlasma S.A. (EPA:ALEUP) Even Though It's 35% Cheaper

ENXTPA:ALEUP 1 Year Share Price vs Fair Value Explore Europlasma's Fair Values from the Community and select yours...
Analysis Article Jun 24

Investors Give Europlasma S.A. (EPA:ALEUP) Shares A 32% Hiding

Unfortunately for some shareholders, the Europlasma S.A. ( EPA:ALEUP ) share price has dived 32% in the last thirty...
Analysis Article Mar 26

A Piece Of The Puzzle Missing From Europlasma S.A.'s (EPA:ALEUP) 50% Share Price Climb

Europlasma S.A. ( EPA:ALEUP ) shareholders are no doubt pleased to see that the share price has bounced 50% in the last...
Analysis Article Oct 08

Investors Continue Waiting On Sidelines For Europlasma S.A. (EPA:ALEUP)

There wouldn't be many who think Europlasma S.A.'s ( EPA:ALEUP ) price-to-sales (or "P/S") ratio of 0.1x is worth a...
Analysis Article May 30

Even With A 74% Surge, Cautious Investors Are Not Rewarding Europlasma S.A.'s (EPA:ALEUP) Performance Completely

Europlasma S.A. ( EPA:ALEUP ) shareholders are no doubt pleased to see that the share price has bounced 74% in the last...
Analysis Article Feb 28

Investors Give Europlasma S.A. (EPA:ALEUP) Shares A 42% Hiding

To the annoyance of some shareholders, Europlasma S.A. ( EPA:ALEUP ) shares are down a considerable 42% in the last...
Analysis Article Apr 18

Europlasma S.A. (EPA:ALEUP) Stock's 57% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Europlasma S.A. ( EPA:ALEUP ) shares have retraced a considerable 57% in the last month, reversing a fair amount of...

Revenue & Expenses Breakdown

How Europlasma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALEUP Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2570-36550
30 Sep 2565-40500
30 Jun 2560-44460
31 Mar 2551-30400
31 Dec 2443-15340
30 Sep 2433-13280
30 Jun 2424-10220
31 Mar 2420-12200
31 Dec 2315-15180
30 Sep 2315-15180
30 Jun 2314-16180
31 Mar 2315-16180
31 Dec 2215-16180
30 Sep 2215-10170
30 Jun 2215-4160
31 Mar 2213-8150
31 Dec 2111-13150
30 Sep 219-11140
30 Jun 217-10130
31 Mar 217-10120
31 Dec 207-10110
30 Sep 205-990
30 Jun 203-970
31 Mar 203-10100
31 Dec 193-11120
30 Sep 197-33150
30 Jun 1911-56180
31 Mar 1912-55170
31 Dec 1814-54160
30 Sep 1816-38160
30 Jun 1817-21150
31 Mar 1816-22150
31 Dec 1716-22140
30 Sep 1713-21140
30 Jun 1710-19140
31 Mar 1711-18140
31 Dec 1612-17140
30 Sep 1613-16150
30 Jun 1614-15150
31 Mar 1615-16150
31 Dec 1516-16150
30 Sep 1515-22140

Quality Earnings: ALEUP is currently unprofitable.

Growing Profit Margin: ALEUP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALEUP is unprofitable, and losses have increased over the past 5 years at a rate of 30.7% per year.

Accelerating Growth: Unable to compare ALEUP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALEUP is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (-2%).


Return on Equity

High ROE: ALEUP's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/12 03:57
End of Day Share Price 2026/07/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Europlasma S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.